July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Differential expression of Ca2+ permeable AMPA receptors among RGC subtypes
Author Affiliations & Notes
  • Scott A Nawy
    Ophthalmology and Visual Sciences, University of Nebraska Medical Center, Omaha, Nebraska, United States
  • Xiangyi Wen
    Ophthalmology and Visual Sciences, University of Nebraska Medical Center, Omaha, Nebraska, United States
  • Asia Lynn Cahill
    Ophthalmology and Visual Sciences, University of Nebraska Medical Center, Omaha, Nebraska, United States
  • Cody Barta
    Ophthalmology and Visual Sciences, University of Nebraska Medical Center, Omaha, Nebraska, United States
  • Wallace B Thoreson
    Ophthalmology and Visual Sciences, University of Nebraska Medical Center, Omaha, Nebraska, United States
  • Footnotes
    Commercial Relationships   Scott Nawy, None; Xiangyi Wen, None; Asia Cahill, None; Cody Barta, None; Wallace Thoreson, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 1858. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Scott A Nawy, Xiangyi Wen, Asia Lynn Cahill, Cody Barta, Wallace B Thoreson; Differential expression of Ca2+ permeable AMPA receptors among RGC subtypes. Invest. Ophthalmol. Vis. Sci. 2018;59(9):1858.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Evidence suggest that specific populations of RGCs show selective vulnerability in animal models of glaucoma. This study was undertaken to determine if differences in expression of AMPA receptors between RGC subtypes might contribute to vulnerability to risk factors of glaucoma. While most neurons have AMPARs that are impermeable to Ca2+ (CI-AMPARs), some express significant numbers of Ca2+ permeable (CP) AMPARs, even into adulthood. Another goal was to determine if elevated pressure, a common feature of glaucoma models, further altered CP-AMPAR expression in RGC subtypes.

Methods : Retinas from 3 mouse lines that label ipRGCs, DS- and α RGCs were cultured for at least 28 days. We assessed the contribution of CP-AMPARs to the overall population of AMPARs using two approaches. One was to measure AMPA-evoked currents in the presence and absence of the CP-AMPAR antagonist PhTX-74. Measurements of block by PhTX were also carried out in parallel on labeled RGCs in the flatmount retina. The second was to image Ca2+ transients evoked by AMPA while blocking Ca2+ channels. Pressure was increased using a custom designed chamber.

Results : At 4-9 DIV, approximately 50% of the AMPA current was carried by CP-AMPARs in ipRGCs, and this fraction dropped to 30% at 21 DIV. Conversely, at 6-8 DIV, CP-AMPAR expression in DS-RGCs and α RGCs was about 85% of total AMPA current. Ca2+ imaging experiments confirmed these findings. DS-RGCs were completely lost from the culture by 10 DIV. Partial rescue of DS-RGCs was accomplished by adding PhTX to the culture media, indicating that CP-AMPARs contributed to cell loss. Pressure treatment of ipRGCs decreased CP-AMPARs, but increased CP-AMPAR in presumed OFF α RGCs and other unidentified RGC types, as determined by both Ca2+ imaging and PhTX application. The effect of pressure was blocked by overexpression of ADAR2, which controls Ca2+ permeability of the GluA2 subunit, and in a transgenic line in which GluA2 is impermeable to Ca2+.

Conclusions : Expression of CP-AMPARs can vary widely between RGC subtypes, and thus could be a contributing factor to susceptibility to diseases such as glaucoma. Elevated pressure may further exacerbate this problem, and the response to pressure also varies by RGC subtype. The pressure mediated increase in CP-AMPAR in DS- and α RGCs may be due to a fall in ADAR2. Conversely, ipRGCs appears to express alternate signaling pathways downstream from pressure transduction.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×